These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 17878520)
1. Cancer stem cells and individualized therapy. Chumsri S; Phatak P; Edelman MJ; Khakpour N; Hamburger AW; Burger AM Cancer Genomics Proteomics; 2007; 4(3):165-74. PubMed ID: 17878520 [TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells: an approach to identify newer therapeutic targets. Srivastava S; Krishna S J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597 [TBL] [Abstract][Full Text] [Related]
3. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Shapira A; Livney YD; Broxterman HJ; Assaraf YG Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184 [TBL] [Abstract][Full Text] [Related]
4. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. Glinsky GV J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Poste G Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734 [TBL] [Abstract][Full Text] [Related]
6. A self-renewal assay for cancer stem cells. Clarke MF Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():64-8. PubMed ID: 16273355 [TBL] [Abstract][Full Text] [Related]
7. Cancer stem cell: target for anti-cancer therapy. Tang C; Ang BT; Pervaiz S FASEB J; 2007 Dec; 21(14):3777-85. PubMed ID: 17625071 [TBL] [Abstract][Full Text] [Related]
8. Successful therapy must eradicate cancer stem cells. Dingli D; Michor F Stem Cells; 2006 Dec; 24(12):2603-10. PubMed ID: 16931775 [TBL] [Abstract][Full Text] [Related]
9. Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines. Komuro H; Saihara R; Shinya M; Takita J; Kaneko S; Kaneko M; Hayashi Y J Pediatr Surg; 2007 Dec; 42(12):2040-5. PubMed ID: 18082704 [TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells and angiogenesis. Zhao Y; Bao Q; Renner A; Camaj P; Eichhorn M; Ischenko I; Angele M; Kleespies A; Jauch KW; Bruns C Int J Dev Biol; 2011; 55(4-5):477-82. PubMed ID: 21732274 [TBL] [Abstract][Full Text] [Related]
11. Induction characterization and targeting of human hematopoietic cancer stem cells. Zhang M; Dias P; Minev B; Koka PS J Stem Cells; 2010; 5(1):1-7. PubMed ID: 20861923 [TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells: never Wnt away from the niche. Malanchi I; Huelsken J Curr Opin Oncol; 2009 Jan; 21(1):41-6. PubMed ID: 19125017 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in cancer stem cells. Cho RW; Clarke MF Curr Opin Genet Dev; 2008 Feb; 18(1):48-53. PubMed ID: 18356041 [TBL] [Abstract][Full Text] [Related]
14. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine. Winquist RJ; Boucher DM; Wood M; Furey BF Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800 [TBL] [Abstract][Full Text] [Related]
15. Migratory strategies of normal and malignant stem cells. Hess DA; Allan AL Methods Mol Biol; 2011; 750():25-44. PubMed ID: 21618081 [TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells: characteristics and their potential role for new therapeutic strategies. Bohl SR; Pircher A; Hilbe W Onkologie; 2011; 34(5):269-74. PubMed ID: 21577035 [TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell targeted agents: therapeutic approaches and consequences. Chumsri S; Burger AM Curr Opin Mol Ther; 2008 Aug; 10(4):323-33. PubMed ID: 18683096 [TBL] [Abstract][Full Text] [Related]
18. Leukemia stem cells in drug resistance and metastasis. Deng CH; Zhang QP Chin Med J (Engl); 2010 Apr; 123(7):954-60. PubMed ID: 20497694 [TBL] [Abstract][Full Text] [Related]
19. The stem cell niche in health and malignancy. Burness ML; Sipkins DA Semin Cancer Biol; 2010 Apr; 20(2):107-15. PubMed ID: 20510363 [TBL] [Abstract][Full Text] [Related]
20. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]